Stocks & Investing
Tue, August 13, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 1, 2024
[ 12:00 AM ] - WOPRAI
Thu, July 25, 2024
[ 12:00 AM ] - WOPRAI
Wed, June 5, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 24, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 10, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 9, 2024
[ 12:00 AM ] - WOPRAI
Tue, April 23, 2024
[ 12:00 AM ] - WOPRAI
Fri, March 22, 2024
[ 12:00 AM ] - WOPRAI
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
Wed, February 14, 2024
[ 12:00 AM ] - WOPRAI
Mon, February 5, 2024
[ 12:00 AM ] - WOPRAI
Mon, January 29, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, September 21, 2023
[ 12:00 AM ] - WOPRAI
Mon, August 7, 2023
[ 12:00 AM ] - WOPRAI
Fri, June 23, 2023
[ 12:00 AM ] - WOPRAI
Tue, April 25, 2023
[ 12:00 AM ] - WOPRAI
Mon, April 24, 2023
[ 12:00 AM ] - WOPRAI
Fri, March 10, 2023
[ 12:00 AM ] - WOPRAI
Tue, February 28, 2023
[ 12:00 AM ] - WOPRAI
Tue, February 21, 2023
[ 12:00 AM ] - WOPRAI
Thu, February 9, 2023
[ 12:00 AM ] - WOPRAI
Wed, February 1, 2023
[ 12:00 AM ] - WOPRAI
Tue, October 25, 2022
[ 12:00 AM ] - WOPRAI
Mon, August 1, 2022
[ 12:00 AM ] - WOPRAI
Tue, April 5, 2022
[ 12:00 AM ] - WOPRAI
Fri, February 18, 2022
[ 12:00 AM ] - WOPRAI
Mon, January 10, 2022 Balaji Prasad Maintained (AMRX) at Buy with Increased Target to $10 on, Aug 13th, 2024
Balaji Prasad of Barclays, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Buy with Increased Target from $8 to $10 on, Aug 13th, 2024.
Balaji has made no other calls on AMRX in the last 4 months.
There are 2 other peers that have a rating on AMRX. Out of the 2 peers that are also analyzing AMRX, 0 agree with Balaji's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Balaji
- Les Sulewski of "Truist Securities" Maintained at Strong Buy with Increased Target to $10 on, Monday, August 12th, 2024
- Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $8 on, Monday, May 6th, 2024
